KIA
ARRY

Kopp Investment Advisors’s Array Biopharma Inc ARRY Stock Holding History

Kopp Investment Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-68,130
Closed -$1.14M – 62
2018
Q2 		$1.14M Sell
68,130
-3,464
-5% -$55.1K 1.07% 28
2018
Q1 		$1.17M Sell
71,594
-41,068
-36% -$658K 1.19% 29
2017
Q4 		$1.44M Sell
112,662
-6,917
-6% -$78.7K 1.44% 27
2017
Q3 		$1.47M Sell
119,579
-1,495
-1% -$13.9K 1.35% 27
2017
Q2 		$1.01M Sell
121,074
-2,393
-2% -$19.6K 0.91% 30
2017
Q1 		$1.1M Sell
123,467
-96,459
-44% -$1.03M 1.08% 28
2016
Q4 		$1.93M Sell
219,926
-109,356
-33% -$805K 2.04% 19
2016
Q3 		$2.22M Sell
329,282
-31,000
-9% -$120K 2.2% 16
2016
Q2 		$1.28M Sell
360,282
-13,575
-4% -$44.2K 0.68% 26
2016
Q1 		$1.1M Sell
373,857
-2,620
-0.7% -$7.85K 0.6% 32
2015
Q4 		$1.59M Sell
376,477
-5,300
-1% -$24.2K 0.78% 24
2015
Q3 		$1.74M Sell
381,777
-1,245
-0.3% -$7.38K 0.94% 25
2015
Q2 		$2.76M Buy
383,022
+1,825
+0.5% +$13.5K 1.23% 22
2015
Q1 		$2.81M Sell
381,197
-218,860
-36% -$1.56M 1.24% 21
2014
Q4 		$2.84M Sell
600,057
-1,405,353
-70% -$5.56M 1.36% 20
2014
Q3 		$7.16M Sell
2,005,410
-6,490
-0.3% -$25.6K 3.54% 10
2014
Q2 		$9.17M Sell
2,011,900
-189,365
-9% -$783K 4.22% 7
2014
Q1 		$10.3M Sell
2,201,265
-27,363
-1% -$138K 4.34% 5
2013
Q4 		$11.2M Sell
2,228,628
-579,909
-21% -$3.16M 5.05% 6
2013
Q3 		$17.5M Sell
2,808,537
-778,591
-22% -$4.63M 6.42% 2
2013
Q2 		$16.3M Buy
+3,587,128
New +$19.3M 6.36% 2

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Kopp Investment Advisors's ARRY Position: Q3 2018 in Review

Kopp Investment Advisors sold out of Array Biopharma Inc (ARRY) in Q3 2018, closing a stake of 68,130 shares — an estimated $1.14M sold.

Kopp Investment Advisors first reported a position in ARRY in Q2 2013 and held it in 21 quarters. The position peaked at $17.5M in Q3 2013. 208 funds tracked by Wall St. Rank hold ARRY as of Q3 2018.

  • Kopp Investment Advisors reported no remaining Array Biopharma Inc position as of Q3 2018 after selling out during the quarter.
  • Kopp Investment Advisors sold 68,130 Array Biopharma Inc shares in Q3 2018, an estimated $1.14M.
  • Kopp Investment Advisors first reported a position in Array Biopharma Inc in Q2 2013 and held it in 21 quarters.
  • Kopp Investment Advisors's Array Biopharma Inc position peaked at $17.5M in Q3 2013.
  • 208 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2018.

Based on Kopp Investment Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.